Hi there,

Today is your last chance to donate during Public Media Giving Days, a time to celebrate what public and independent media gives to you by giving back. If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. In honor of Public Media Giving Days, a generous donor will TRIPLE your donation, which means it’ll go 3x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets tripled! Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

WHO Expands Vaccine Program, Repeats Calls on Drugmakers to Share Technology

HeadlineFeb 24, 2022

The World Health Organization says it’s opening a global biomanufacturing hub in South Korea to train people in low- and middle-income countries to produce vaccines and therapeutics used to fight COVID-19. The WHO also said Wednesday it will transfer technology from its South African mRNA vaccine hub to five more countries: Bangladesh, Indonesia, Pakistan, Serbia and Vietnam. The WHO has produced a prototype COVID vaccine based on technology reverse-engineered from Moderna’s mRNA shot, but the vaccine could still take more than a year to test and develop. Top WHO scientist Dr. Soumya Swaminathan said Wednesday that Moderna and Pfizer could help rapidly speed up the process by sharing their patented technologies with the world.

Dr. Soumya Swaminathan: “We would very much welcome a partnership with them, because, as we were describing, you know, the development from scratch of a vaccine does take time, … which means that it’s not going to be really available as a vaccine that — before the end of 2023, or more likely 2024. This can be — this timeline can obviously be shortened considerably if a known technology, a known vaccine, with proven efficacy and safety, were to transfer their know-how.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top